Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/27/24 | $100,000,000 | Series A |
Forbion Capital Partners RA Capital Management | undisclosed |
